$CTM
Castellum, Inc.

2022 Q4 Form 10-Q Financial Statement

#000157587222001095 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2022 Q2
Revenue $10.02M $11.12M $11.06M
YoY Change 50.73%
Cost Of Revenue $5.895M $6.474M $6.369M
YoY Change 50.23%
Gross Profit $4.130M $4.646M $4.686M
YoY Change 51.42%
Gross Profit Margin 41.2% 41.78% 42.39%
Selling, General & Admin $3.954M
YoY Change
% of Gross Profit 95.73%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.032M $34.11K $6.150K
YoY Change
% of Gross Profit 49.21% 0.73% 0.13%
Operating Expenses $8.748M $6.700M $7.433M
YoY Change -12.64%
Operating Profit -$4.617M -$2.053M -$2.746M
YoY Change -55.37%
Interest Expense -$1.448M
YoY Change
% of Operating Profit
Other Income/Expense, Net -$902.3K -$1.085M
YoY Change 39.21%
Pretax Income -$5.756M -$2.995M -$3.831M
YoY Change -42.92%
Income Tax -$83.22K $159.0K $893.4K
% Of Pretax Income
Net Earnings -$5.703M -$3.144M -$4.754M
YoY Change -36.13% 474.7%
Net Earnings / Revenue -56.89% -28.28% -43.0%
Basic Earnings Per Share -$0.12 -$0.20
Diluted Earnings Per Share -$0.14 -$0.12 -$0.20
COMMON SHARES
Basic Shares Outstanding 41.54M 25.87M 23.89M shares
Diluted Shares Outstanding 25.87M 23.89M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.641M
YoY Change
Cash & Equivalents $4.641M $1.853M $2.058M
Short-Term Investments
Other Short-Term Assets $574.1K
YoY Change
Inventory
Prepaid Expenses
Receivables $5.194M $8.466M
Other Receivables $0.00
Total Short-Term Assets $10.67M $10.63M
YoY Change 29.93%
LONG-TERM ASSETS
Property, Plant & Equipment $173.4K $190.9K
YoY Change 18.9%
Goodwill $15.53M $15.53M
YoY Change 10.46%
Intangibles $6.634M $7.132M
YoY Change -12.66%
Long-Term Investments
YoY Change
Other Assets $0.00
YoY Change
Total Long-Term Assets $22.38M $22.92M
YoY Change -0.75%
TOTAL ASSETS
Total Short-Term Assets $10.67M $10.63M
Total Long-Term Assets $22.38M $22.92M
Total Assets $33.04M $33.55M
YoY Change 7.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.618M
YoY Change
Accrued Expenses $1.892M
YoY Change
Deferred Revenue $82.58K
YoY Change
Short-Term Debt $300.0K
YoY Change
Long-Term Debt Due $2.033M
YoY Change
Total Short-Term Liabilities $7.759M $8.768M
YoY Change 52.19%
LONG-TERM LIABILITIES
Long-Term Debt $7.740M
YoY Change
Other Long-Term Liabilities $12.63K
YoY Change
Total Long-Term Liabilities $7.753M $7.626M
YoY Change -25.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.759M $8.768M
Total Long-Term Liabilities $7.753M $7.626M
Total Liabilities $15.51M $16.39M
YoY Change 0.5%
SHAREHOLDERS EQUITY
Retained Earnings -$26.09M -$20.39M
YoY Change 135.38%
Common Stock $4.170K $2.479K
YoY Change 108.92%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $17.53M $17.16M $19.13M
YoY Change
Total Liabilities & Shareholders Equity $33.04M $33.55M
YoY Change 7.44%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2022 Q2
OPERATING ACTIVITIES
Net Income -$5.703M -$3.144M -$4.754M
YoY Change -36.13% 474.7%
Depreciation, Depletion And Amortization $2.032M $34.11K $6.150K
YoY Change
Cash From Operating Activities $990.2K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures $89.28K
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$250.0K
YoY Change
Cash From Investing Activities -$339.3K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.972M
YoY Change
NET CHANGE
Cash From Operating Activities 990.2K
Cash From Investing Activities -339.3K
Cash From Financing Activities 1.972M
Net Change In Cash 2.623M
YoY Change
FREE CASH FLOW
Cash From Operating Activities $990.2K
Capital Expenditures $89.28K
Free Cash Flow $900.9K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
902820
dei Entity Registrant Name
EntityRegistrantName
CASTELLUM, INC.
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity File Number
EntityFileNumber
001-41526
dei Entity Central Index Key
EntityCentralIndexKey
0001877939
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-4079982
dei Entity Address Address Line1
EntityAddressAddressLine1
3 Bethesda Metro Center
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 700
dei Entity Address City Or Town
EntityAddressCityOrTown
Bethesda
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20814
dei City Area Code
CityAreaCode
301
dei Local Phone Number
LocalPhoneNumber
961-4895
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
CTM
dei Security Exchange Name
SecurityExchangeName
NYSEAMER
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
41539342
CY2022Q3 us-gaap Cash
Cash
1853388
CY2021Q4 us-gaap Cash
Cash
2017915
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8465979
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5414401
CY2021Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
591055
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
310569
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
185824
CY2022Q3 us-gaap Assets Current
AssetsCurrent
10629936
CY2021Q4 us-gaap Assets Current
AssetsCurrent
8209195
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
190942
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
145792
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
610033
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
65503
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
132690
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7131860
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7595599
CY2022Q3 us-gaap Goodwill
Goodwill
15533964
CY2021Q4 us-gaap Goodwill
Goodwill
14062964
CY2022Q3 us-gaap Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment
AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment
22731327
CY2021Q4 us-gaap Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment
AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment
22401286
CY2022Q3 us-gaap Assets
Assets
33552205
CY2021Q4 us-gaap Assets
Assets
30756273
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1644838
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1437827
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2106252
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1511622
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
82583
CY2022Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
591003
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
200000
CY2022Q3 ctm Obligation To Issue Common And Preferred Stock
ObligationToIssueCommonAndPreferredStock
125000
CY2021Q4 ctm Obligation To Issue Common And Preferred Stock
ObligationToIssueCommonAndPreferredStock
25000
CY2021Q4 us-gaap Asset Acquisition Contingent Consideration Liability Current
AssetAcquisitionContingentConsiderationLiabilityCurrent
275000
CY2022Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
1121000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
257000
CY2022Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
789000
CY2022Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
300025
CY2022Q3 us-gaap Notes Payable Current
NotesPayableCurrent
1960402
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
1279390
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
47617
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
111999
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
8767720
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5097838
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
16743
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
18715
CY2022Q3 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
400000
CY2021Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
400000
CY2022Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
696826
CY2021Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
2805184
CY2022Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
6512019
CY2021Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
7112419
CY2022Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
7625588
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
10336318
CY2022Q3 us-gaap Liabilities
Liabilities
16393308
CY2021Q4 us-gaap Liabilities
Liabilities
15434156
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24788132
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24788132
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19960632
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19960632
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
2479
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
1996
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
37546787
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
26405126
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-20391341
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11086016
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
17158897
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
15322117
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
33552205
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
30756273
CY2022Q3 us-gaap Revenues
Revenues
11120712
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-890995
CY2021Q3 us-gaap Revenues
Revenues
7378094
us-gaap Revenues
Revenues
32166104
us-gaap Revenues
Revenues
15587246
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
6474261
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
4309439
us-gaap Cost Of Revenue
CostOfRevenue
18698820
us-gaap Cost Of Revenue
CostOfRevenue
8921153
CY2022Q3 us-gaap Gross Profit
GrossProfit
4646451
CY2021Q3 us-gaap Gross Profit
GrossProfit
3068655
us-gaap Gross Profit
GrossProfit
13467284
us-gaap Gross Profit
GrossProfit
6666093
CY2022Q3 ctm Indirect Costs
IndirectCosts
2130513
CY2021Q3 ctm Indirect Costs
IndirectCosts
738239
ctm Indirect Costs
IndirectCosts
7458319
ctm Indirect Costs
IndirectCosts
1512370
CY2022Q3 ctm Overhead Costs
OverheadCosts
407804
CY2021Q3 ctm Overhead Costs
OverheadCosts
248540
ctm Overhead Costs
OverheadCosts
1167346
ctm Overhead Costs
OverheadCosts
431987
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3297319
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6682034
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9633064
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10389922
CY2022Q3 ctm Loss From Change In Fair Value Of Contingent Earnout
LossFromChangeInFairValueOfContingentEarnout
864000
CY2021Q3 ctm Loss From Change In Fair Value Of Contingent Earnout
LossFromChangeInFairValueOfContingentEarnout
0
ctm Loss From Change In Fair Value Of Contingent Earnout
LossFromChangeInFairValueOfContingentEarnout
864000
ctm Loss From Change In Fair Value Of Contingent Earnout
LossFromChangeInFairValueOfContingentEarnout
0
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
6699636
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
7668813
us-gaap Operating Expenses
OperatingExpenses
19122729
us-gaap Operating Expenses
OperatingExpenses
12334279
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2053185
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4600158
us-gaap Operating Income Loss
OperatingIncomeLoss
-5655445
us-gaap Operating Income Loss
OperatingIncomeLoss
-5668186
CY2022Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0
CY2021Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
38851
CY2022Q3 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0
CY2021Q3 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
303
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0
CY2022Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-76000
CY2021Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
97000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-978314
CY2021Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-648175
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-2579915
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1838032
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-902314
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-648175
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2676612
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1799181
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2995499
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5248333
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-3114524
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-4919598
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8332057
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7467367
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
159025
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-328735
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1342181
us-gaap Profit Loss
ProfitLoss
-9234877
us-gaap Profit Loss
ProfitLoss
-6576372
CY2022Q3 ctm Preferred Stock Dividends
PreferredStockDividends
29911
CY2021Q3 ctm Preferred Stock Dividends
PreferredStockDividends
3320
ctm Preferred Stock Dividends
PreferredStockDividends
70447
ctm Preferred Stock Dividends
PreferredStockDividends
3320
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-3144435
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-4922918
us-gaap Net Income Loss
NetIncomeLoss
-9305324
us-gaap Net Income Loss
NetIncomeLoss
-6579692
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.26
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.26
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.39
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.39
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.38
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.38
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25868849
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25868849
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18679462
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18679462
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23621551
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23621551
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17414469
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17414469
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
2608526
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
263610
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-829532
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
2230790
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
407271
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-827242
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
3193256
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1600217
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-4922918
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
9986471
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
15322117
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
875640
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
30937
CY2022Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
6188
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
12000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1406715
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
14990167
CY2022Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
11940
CY2022Q2 ctm Shares Issued For Cash Including Fair Value Adjustment
SharesIssuedForCashIncludingFairValueAdjustment
593000
CY2022Q2 ctm Shares Issued For Commitment Fees
SharesIssuedForCommitmentFees
59300
CY2022Q2 ctm Shares Issued To Satisfy Obligation To Issue Common Stock
SharesIssuedToSatisfyObligationToIssueCommonStock
533750
CY2022Q3 ctm Adjustment To Additional Paid In Capital Gain Loss On Conversion Of Related Party Debt
AdjustmentToAdditionalPaidInCapitalGainLossOnConversionOfRelatedPartyDebt
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-3144435
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
17158897
us-gaap Share Based Compensation
ShareBasedCompensation
4906152
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1117335
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
30938
CY2022Q2 ctm Adjustment To Additional Paid In Capital Gain Loss On Conversion Of Related Party Debt
AdjustmentToAdditionalPaidInCapitalGainLossOnConversionOfRelatedPartyDebt
2667903
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-4754175
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
19133377
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1139018
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
30937
us-gaap Profit Loss
ProfitLoss
-9234877
us-gaap Profit Loss
ProfitLoss
-6576372
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1520329
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1126047
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1869152
ctm Increase Decrease In Business Transaction Cost
IncreaseDecreaseInBusinessTransactionCost
-50500
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
801641
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
511806
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-554647
ctm Increase Decrease In Contract Asset Liability
IncreaseDecreaseInContractAssetLiability
569610
ctm Increase Decrease In Business Transaction Cost
IncreaseDecreaseInBusinessTransactionCost
0
us-gaap Share Based Compensation
ShareBasedCompensation
5305700
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
610033
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1025852
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
303
ctm Financing Fee And Bank Charges For Note Payable And Advances On Revolving Credit Line
FinancingFeeAndBankChargesForNotePayableAndAdvancesOnRevolvingCreditLine
-3775
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
38851
us-gaap Operating Lease Cost
OperatingLeaseCost
833
us-gaap Operating Lease Cost
OperatingLeaseCost
476
ctm Legal Fees Incurred Out Of Proceeds Of Notes Payable
LegalFeesIncurredOutOfProceedsOfNotesPayable
30000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
864000
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-97000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2637969
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-144601
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
58051
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2014
ctm Increase Decrease In Contract Asset Liability
IncreaseDecreaseInContractAssetLiability
-673638
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
167612
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
250000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
365572
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
92436
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5346
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-342436
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
835989
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
300000
ctm Proceeds From Issuance Of Preferred And Common Stock
ProceedsFromIssuanceOfPreferredAndCommonStock
625000
ctm Proceeds From Issuance Of Preferred And Common Stock
ProceedsFromIssuanceOfPreferredAndCommonStock
420000
us-gaap Proceeds From Issuance Of Medium Term Notes
ProceedsFromIssuanceOfMediumTermNotes
1470000
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
70449
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
3320
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
12000
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
500000
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
70000
ctm Payment Of Amount Due To Seller Towards Purchase Consideration
PaymentOfAmountDueToSellerTowardsPurchaseConsideration
160000
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
3460
us-gaap Repayments Of Medium Term Notes
RepaymentsOfMediumTermNotes
943995
us-gaap Repayments Of Medium Term Notes
RepaymentsOfMediumTermNotes
104244
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
732556
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
238976
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-164527
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1242577
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2017915
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2412382
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1853388
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3654959
us-gaap Interest Paid Net
InterestPaidNet
559234
us-gaap Interest Paid Net
InterestPaidNet
474414
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
16400
ctm Debt Discount On Note Payable Applied To Obligation To Issue Common Stock
DebtDiscountOnNotePayableAppliedToObligationToIssueCommonStock
500000
ctm Adjustment To Contingent Consideration And Customer Relationships
AdjustmentToContingentConsiderationAndCustomerRelationships
275000
ctm Adjustment To Additional Paid In Capital Gain Losses On Conversion Of Related Party Debt One
AdjustmentToAdditionalPaidInCapitalGainLossesOnConversionOfRelatedPartyDebtOne
2667903
us-gaap Stock Issued1
StockIssued1
533750
ctm Derivative Liability Recognized As Discount Of Note Payable
DerivativeLiabilityRecognizedAsDiscountOfNotePayable
692000
ctm Deferred Issuance Costs Recognized For Note Payable
DeferredIssuanceCostsRecognizedForNotePayable
59300
ctm Fair Value Adjustment Recognized On Issuance Of Common Stock In Securities Purchase Agreement
FairValueAdjustmentRecognizedOnIssuanceOfCommonStockInSecuritiesPurchaseAgreement
93000
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
5350
ctm Cancellation Of Shares Issued On Acquisition
CancellationOfSharesIssuedOnAcquisition
400000
us-gaap Nature Of Operations
NatureOfOperations
<div style="margin:0in 0in 0.0001pt; line-height:normal; font-family:Calibri,sans-serif;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;">NOTE 1: NATURE OF OPERATIONS</div></div></div> <div style="margin: 0in 0in 0.0001pt; line-height: normal; font-family: Calibri, sans-serif; font-size: 12pt;;text-indent: 0px;"><div style="font-size: 12pt; font-family: &quot;Times New Roman&quot;, serif; white-space: pre-wrap; letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div> <div style="margin: 0in 0in 0.0001pt; text-align: justify; line-height: normal; font-family: Calibri, sans-serif; font-size: 10pt;;text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;">Castellum, Inc. (the “Company”) is focused on acquiring and growing technology companies in the areas of information technology, electronic warfare, information warfare and cybersecurity with businesses in the governmental and commercial markets. Services include intelligence analysis, software development, software engineering, program management, strategic planning, information assurance and cybersecurity and policy along with analysis support. These services, which largely focus on securing data and establishing related policies, are applicable to customers in the federal government, financial services, healthcare and other users of large data applications. The services can be delivered to legacy, customer owned networks or customers who rely upon cloud-based infrastructures. The Company has worked with multiple business brokers and contacts within </div><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;">its </div> <div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;"> business network to identify potential acquisitions.</div></div> <div style="margin: 0in 0in 0.0001pt; text-align: justify; line-height: normal; font-family: Calibri, sans-serif; font-size: 10pt;;text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; white-space: pre-wrap; letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"/></div> <div style="margin: 0in 0in 0.0001pt; text-align: justify; line-height: normal; font-family: Calibri, sans-serif; font-size: 10pt;;text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; white-space: pre-wrap; letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div> <div style="margin: 0in 0in 0.0001pt; text-align: justify; line-height: normal; font-family: Calibri, sans-serif; font-size: 10pt;;text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;"><div style="display:inline;">S</div>ince November 2019, the Company has made the following acquisitions that specialize in the areas noted above:</div></div> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr> <td style="width:.25in; padding:0in 0in 0in 0in;vertical-align:top;"/> <td style="width:.25in; padding:0in 0in 0in 0in;vertical-align:top;"> <div style="margin: 0in 0in 0.0001pt; line-height: normal; font-family: Calibri, sans-serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: Symbol; letter-spacing: 0px; top: 0px;;display:inline;">·</div></div> </td> <td style="padding:0in 0in 0in 0in;vertical-align:top;"> <div style="margin: 0in 0in 0.0001pt; text-align: justify; line-height: normal; font-family: Calibri, sans-serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;">Corvus Consulting, LLC (“Corvus”),</div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="margin: 0in 0in 0.0001pt; line-height: normal; font-family: Calibri, sans-serif; font-size: 12pt;;text-indent: 0px;"/> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr> <td style="width:.25in; padding:0in 0in 0in 0in;vertical-align:top;"/> <td style="width:.25in; padding:0in 0in 0in 0in;vertical-align:top;"> <div style="margin: 0in 0in 0.0001pt; line-height: normal; font-family: Calibri, sans-serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: Symbol; letter-spacing: 0px; top: 0px;;display:inline;">·</div></div> </td> <td style="padding:0in 0in 0in 0in;vertical-align:top;"> <div style="margin: 0in 0in 0.0001pt; text-align: justify; line-height: normal; font-family: Calibri, sans-serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;">Mainnerve Federal Services, Inc. dba MFSI Government Group (“MFSI),</div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="margin: 0in 0in 0.0001pt; line-height: normal; font-family: Calibri, sans-serif; font-size: 12pt;;text-indent: 0px;"/> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr> <td style="width:.25in; padding:0in 0in 0in 0in;vertical-align:top;"/> <td style="width:.25in; padding:0in 0in 0in 0in;vertical-align:top;"> <div style="margin: 0in 0in 0.0001pt; line-height: normal; font-family: Calibri, sans-serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: Symbol; letter-spacing: 0px; top: 0px;;display:inline;">·</div></div> </td> <td style="padding:0in 0in 0in 0in;vertical-align:top;"> <div style="margin: 0in 0in 0.0001pt; text-align: justify; line-height: normal; font-family: Calibri, sans-serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;">Merrison Technologies, LLC (“Merrison”),</div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="margin: 0in 0in 0.0001pt; line-height: normal; font-family: Calibri, sans-serif; font-size: 12pt;;text-indent: 0px;"/> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr> <td style="width:.25in; padding:0in 0in 0in 0in;vertical-align:top;"/> <td style="width:.25in; padding:0in 0in 0in 0in;vertical-align:top;"> <div style="margin: 0in 0in 0.0001pt; line-height: normal; font-family: Calibri, sans-serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: Symbol; letter-spacing: 0px; top: 0px;;display:inline;">·</div></div> </td> <td style="padding:0in 0in 0in 0in;vertical-align:top;"> <div style="margin: 0in 0in 0.0001pt; text-align: justify; line-height: normal; font-family: Calibri, sans-serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;">Specialty Systems, Inc. (“SSI”),</div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="margin: 0in 0in 0.0001pt; line-height: normal; font-family: Calibri, sans-serif; font-size: 12pt;;text-indent: 0px;"/> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr> <td style="width:.25in; padding:0in 0in 0in 0in;vertical-align:top;"/> <td style="width:.25in; padding:0in 0in 0in 0in;vertical-align:top;"> <div style="margin: 0in 0in 0.0001pt; line-height: normal; font-family: Calibri, sans-serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: Symbol; letter-spacing: 0px; top: 0px;;display:inline;">·</div></div> </td> <td style="padding:0in 0in 0in 0in;vertical-align:top;"> <div style="margin: 0in 0in 0.0001pt; text-align: justify; line-height: normal; font-family: Calibri, sans-serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;">the business assets of Pax River from The Albers Group (“Pax River”), and</div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="margin: 0in 0in 0.0001pt; line-height: normal; font-family: Calibri, sans-serif; font-size: 12pt;;text-indent: 0px;"/> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr> <td style="width:.25in; padding:0in 0in 0in 0in;vertical-align:top;"/> <td style="width:.25in; padding:.75pt 0in .75pt 0in;vertical-align:top;"> <div style="margin: 0in 0in 0.0001pt; text-align: justify; line-height: normal; font-family: Calibri, sans-serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: Symbol; letter-spacing: 0px; top: 0px;;display:inline;">·</div></div> </td> <td style="padding:.75pt 0in .75pt 0in;vertical-align:top;"> <div style="margin: 0in 0in 0.0001pt; text-align: justify; line-height: normal; font-family: Calibri, sans-serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;">Lexington Solutions Group, LLC (“LSG”).</div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="margin: 0in 0in 0.0001pt; text-align: justify; line-height: normal; font-family: Calibri, sans-serif; font-size: 12pt;;text-indent: 0px;"><div style="font-size: 12pt; font-family: Calibri, sans-serif; white-space: pre-wrap; letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div> <div style="margin:0in 0in 0.0001pt; text-align:justify; line-height:normal; font-family:Calibri,sans-serif;text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;">With the exception of Pax River, all of these acquisitions were considered business combinations under Topic 805 <div style="font-style:italic;display:inline;">Business Combinations</div> of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”). See Note 3, “Acquisitions” for greater details on the acquisitions of the Company since January 1, 2021.</div></div> <div style="margin: 0in 0in 0.0001pt; text-align: justify; line-height: normal; font-family: Calibri, sans-serif; font-size: 10pt;;text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; white-space: pre-wrap; letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div> <div style="margin: 0in 0in 0.0001pt; line-height: normal; font-family: Calibri, sans-serif; font-size: 10pt;;text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;">On July 19, 2021, the Company filed a Certificate of Amendment with the State of Nevada to change the par value of all common and preferred stock to be $0.0001. All changes to the par value dollar amount for these classes of stock and adjustment to additional paid in capital have been made retroactively.</div></div> <div style="margin: 0in 0in 0.0001pt; line-height: normal; font-family: Calibri, sans-serif; font-size: 10pt;;text-indent: 0px;"><div style="font-size: 10pt; font-family: Calibri, sans-serif; white-space: pre-wrap; letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div> <div style="margin:0in 0in 0.0001pt; text-align:justify; line-height:normal; font-family:Calibri,sans-serif;text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;">On April 7, 2022, the Company filed a Certificate of Amendment for </div><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;">its </div><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;">Series A Preferred Stock to (a) provide for an annualized dividend of $0.0125 per share </div><div style="font-size: 8pt; font-family: Calibri, sans-serif; white-space:pre-line; letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;">to be paid monthly; (b) amend the conversion ratio for each share of Series A Preferred Stock </div><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;">to convert </div> <div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;"> into 2 shares of common stock instead of 20 shares of common stock; and (c) providing for the Company to have the option to repurchase the Series A Preferred Stock at any time at a price of $1 per share.</div></div> <div style="margin: 0in 0in 0.0001pt; text-align: justify; line-height: normal; font-family: Calibri, sans-serif; font-size: 10pt;;text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; white-space: pre-wrap; letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div> <div style="margin: 0in 0in 0.0001pt; text-align: justify; line-height: normal; font-family: Calibri, sans-serif; font-size: 10pt;;text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;">The events related to COVID-19, the disease caused by the novel coronavirus (SARS-CoV-2) and its variants, have had significant health, economic, and market impacts and may have short-term and long-term adverse effects on our business that we cannot predict as the global pandemic continues to evolve. The extent and effectiveness of responses by governments and other organizations also cannot be predicted. Our ability to access the capital markets and maintain existing operations has been little affected during the COVID-19 pandemic. Going forward any possible adverse effects on the business are uncertain given any possible limitations on available financing and how we conduct business with our customers and vendors.</div></div>
CY2022Q3 us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
0.0125
CY2022Q4 ctm Stockholders Equity Note Stock Split Conversion Ratio
StockholdersEquityNoteStockSplitConversionRatio
2 shares of common stock instead of 20 shares of common stock
CY2022Q3 us-gaap Preferred Stock Redemption Price Per Share
PreferredStockRedemptionPricePerShare
1
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2021 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
us-gaap Use Of Estimates
UseOfEstimates
<div style="background: white; margin: 0pt 0in; text-align: justify; font-family: &quot;Times New Roman&quot;, serif; text-indent: 0px; line-height: 12pt;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;">Use of Estimates</div></div></div></div> <div style="margin: 0pt 0in; text-align: justify; line-height: 12pt; font-family: Calibri, sans-serif; font-size: 10pt; text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; white-space: pre-wrap; letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div> <div style="margin: 0pt 0in; text-align: justify; line-height: 12pt; font-family: Calibri, sans-serif; font-size: 10pt; text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of </div><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;">condensed </div> <div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;">consolidated financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and reported amounts of revenues and expenses during the reporting period. These estimates include, but are not limited to, management’s estimate of provisions required for uncollectible accounts receivable, the acquired value of the intangible assets, impaired value of intangible assets, liabilities to accrue, cost incurred in the satisfaction of performance obligations, fair value for consideration elements of business combinations, permanent and temporary differences related to income taxes and determination of the fair value of stock awards. Actual results could differ from those estimates.</div></div>
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
32166104
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15587246
ctm Minimum Percentage Of The Largest Amount Of Tax Benefit Likely To Be Realized Upon Ultimate Settlement With The Related Tax Authority
MinimumPercentageOfTheLargestAmountOfTaxBenefitLikelyToBeRealizedUponUltimateSettlementWithTheRelatedTaxAuthority
0.50
CY2022Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1080717
CY2022Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
33685580
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-7843711
us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
-0.33
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
20333508
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-127660
us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
0
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
257572
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
167987
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
66630
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
22195
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
190942
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
145792
us-gaap Depreciation
Depreciation
47589
us-gaap Depreciation
Depreciation
7329
CY2022Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
12454863
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
11445863
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5323003
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3850264
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7131860
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7595599
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1472740
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1123590
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths
1969588
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1653245
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo
985482
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree
721751
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour
526950
CY2022Q3 ctm Finite Lived Intangible Assets Amortization Expense Rolling After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFour
1274844
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7131860
CY2021Q4 us-gaap Goodwill
Goodwill
14062964
CY2020Q4 us-gaap Goodwill
Goodwill
4136011
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
1471000
CY2021 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
9926953
ctm Goodwill Disposals
GoodwillDisposals
CY2021 ctm Goodwill Disposals
GoodwillDisposals
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
CY2022Q3 us-gaap Goodwill
Goodwill
15533964
CY2021Q4 us-gaap Goodwill
Goodwill
14062964
CY2022Q3 us-gaap Notes Payable
NotesPayable
9794380
CY2021Q4 us-gaap Notes Payable
NotesPayable
9188374
CY2022Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
1321959
CY2021Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
796565
CY2022Q3 us-gaap Long Term Debt
LongTermDebt
8472421
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
8391809
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
173000
us-gaap Interest Expense Debt
InterestExpenseDebt
1325885
us-gaap Interest Expense Debt
InterestExpenseDebt
608706
CY2022Q3 us-gaap Interest Payable Current
InterestPayableCurrent
27525
CY2022Q3 us-gaap Business Combination Liabilities Arising From Contingencies Amount Recognized
BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized
551003
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
ctm Payment Of Dividend On Preferred Stock
PaymentOfDividendOnPreferredStock
30569
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24788132
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24788132
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19960632
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19960632
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3131993
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2271097
CY2022Q3 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
15647325
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
1.14
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
1.26
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
1.35
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
1.77
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.02
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0285
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.001
CY2022Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
789000
CY2022Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
1121000
CY2022Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
1910000
CY2021Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
0
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
257000
CY2021Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
257000
CY2022Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
789000
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0
CY2022Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
692000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
97000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
692000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-97000
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
789000
ctm Employment Agreements End Date
EmploymentAgreementsEndDate
2025-06-30
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.105
CY2021Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.063
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.127
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.119

Files In Submission

Name View Source Status
0001575872-22-001095-index-headers.html Edgar Link pending
0001575872-22-001095-index.html Edgar Link pending
0001575872-22-001095.txt Edgar Link pending
0001575872-22-001095-xbrl.zip Edgar Link pending
ctm-20220930.htm Edgar Link pending
ctm-20220930.xsd Edgar Link pending
ctm-20220930_cal.xml Edgar Link unprocessable
ctm-20220930_def.xml Edgar Link unprocessable
ctm-20220930_htm.xml Edgar Link completed
Financial_Report.xlsx Edgar Link pending
lb044_ex10-23.htm Edgar Link pending
lb044_ex10-23img01.jpg Edgar Link pending
lb044_ex10-23img02.jpg Edgar Link pending
lb044_ex31-1.htm Edgar Link pending
lb044_ex31-2.htm Edgar Link pending
lb044_ex32-1.htm Edgar Link pending
lb044_ex32-2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
ctm-20220930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ctm-20220930_lab.xml Edgar Link unprocessable